Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Diagnosis
12 results:

  • 1. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and foxp3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon.
    Yılmaz O; Crabbe A; Neyaz A; Pankaj A; Lee SH; Hosseini S; Rickelt S; Cerda S; Zhao Q; Leijsen L; Dineaux A; Shroff SG; Crotty R; Zhang ML; Yilmaz OH; Patil DT; Berger D; Deshpande V
    Histopathology; 2022 Sep; 81(3):380-388. PubMed ID: 35789111
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.
    Ugai T; Väyrynen JP; Lau MC; Borowsky J; Akimoto N; Väyrynen SA; Zhao M; Zhong R; Haruki K; Dias Costa A; Fujiyoshi K; Arima K; Wu K; Chan AT; Cao Y; Song M; Fuchs CS; Wang M; Lennerz JK; Ng K; Meyerhardt JA; Giannakis M; Nowak JA; Ogino S
    Cancer Immunol Immunother; 2022 Apr; 71(4):933-942. PubMed ID: 34529108
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
    Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
    Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Influence of the Genetic and Immunologic Context in the Development of colorectal Adenoma: A Case Series Report.
    Garcia D; Spaans L; Miranda S; Gonçalves G; Reis J; Costa JL; Durães C; Carneiro F; Machado JC
    Acta Med Port; 2020 May; 33(5):297-304. PubMed ID: 32416752
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
    Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
    [No Abstract]    [Full Text] [Related]  

  • 7. Identification of Prognostic Biomarker Signatures and Candidate Drugs in colorectal cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis.
    Laissue P
    Mol Cancer; 2019 Jan; 18(1):5. PubMed ID: 30621735
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in colorectal cancer.
    Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
    Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lymphocytic follicles and aggregates are a determinant of mucosal damage and duration of diarrhea.
    Shah N; Thakkar B; Shen E; Loh M; Chong PY; Gan WH; Tu TM; Shen L; Soong R; Salto-Tellez M
    Arch Pathol Lab Med; 2013 Jan; 137(1):83-9. PubMed ID: 23276179
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients.
    Girardin A; McCall J; Black MA; Edwards F; Phillips V; Taylor ES; Reeve AE; Kemp RA
    Int J Cancer; 2013 Apr; 132(8):1842-50. PubMed ID: 23002055
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regulatory (foxp3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.
    Correale P; Rotundo MS; Del Vecchio MT; Remondo C; Migali C; Ginanneschi C; Tsang KY; Licchetta A; Mannucci S; Loiacono L; Tassone P; Francini G; Tagliaferri P
    J Immunother; 2010 May; 33(4):435-41. PubMed ID: 20386463
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.